chevron_leftBack
As of 14 June 2026, VolitionRx Ltd. has a market cap of $20.92M USD, ranking #36773 globally and #4976 in the United States.
It ranks #3302 in the Healthcare sector, and #701 in the Medical Devices industry.
Key Stats
Market Cap
$20.92MUSD
Enterprise Value
$31.27MUSD
Revenue (TTM)
$1.73MUSD
EBITDA (TTM)
-$20.75MUSD
Net Income (TTM)
-$23.36MUSD
PS Ratio
12.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Cameron Reynolds
open_in_new
Employees
75
Website
volition.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -5.5% | -16% | -33% | -49% | -69% | -71% |
News
Loading...
VNRX Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
VNRX
ISIN: US9286612067
Shares Out.:
Shares Outstanding:
8.627M1
Shares Float:
7.253M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
2.64 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About VolitionRx Ltd.
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
828K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
768K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
760K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
605K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
577K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
406K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
487K%
|
22.2
|
|
EPA: EL
|
$97.46B
466K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
293K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
217K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
174K%
28.99B CHF
|
37.9
|
|
|
$30.06B
144K%
203.66B CNY
|
26.0
|
chevron_leftBack